ReviewBiomedicines2021

Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer's Disease and Diabetes.

Gabriela Dumitrita Stanciu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.